Efficacy and safety of vismodegib in periocular and orbital basal cell carcinoma: a systematic review and meta-analysis
BackgroundPeriocular and orbital basal cell carcinoma (BCC) represents a therapeutic challenge due to its proximity to critical structures, the risk of disfigurement, and the potential need for exenteration in advanced disease. Vismodegib, a Hedgehog pathway inhibitor, offers a non-surgical alternat...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2026-05-01
|
| coleção: | Frontiers in Medicine |
| Assuntos: | |
| Acesso em linha: | https://www.frontiersin.org/articles/10.3389/fmed.2026.1722574/full |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
